ANALYSIS OF THE TRADITIONAL RISK FACTORS INFLUENCE ON DEVELOPMENT OF ISCHEMIC HEART DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA

Familial hypercholesterolemia (FH) is inherited pathology with increased level of cholesterol, and predisposes for early development of atherosclerosis, but prevalence of cardiovascular pathology in FH patients varies, and demands for more precise definition of additional factors of risk of ischemic heart disease (IHD).

Aim. To evaluate in FH patients an association of IHD and classical risk factors (sex, age, arterial hypertension (AH), smoking, obesity, cholesterol of low density lipoproteides (LDL-C) and high density (HDL-C), complicated heredity for cardiovascular disorders), mutation of LDL receptors.

Material and methods. Totally, 253 patients studied, age 18 and older, with heterozygous FCHE, diagnoses according to Dutch Lipid Clinic Network, (mean age — 51±3,4 y. o.). 109 patients (43%) underwent genetic test. IHD was diagnosed in 106 (41,8%), anamnesis of acute myocardial infarction (MI) had 63 (24,9%) patients.

Results. In FH, IHD was associated with the following risk factors: AH, age older 40 y., complicated inheritance for cardiovascular pathology. An increase of LDL-C level by every1 mM increased the prevalence of CHD in heterozygous FCHE patients by 4,5% up to LDL-C 8,5 mM/L. In higher LDL-C values IHD prevalence increases by 1-2%. In patients with mutation of LDL receptor, IHD develops 5 years earlier. There was no association revealed for the type of mutation and IHD.

Conclusion. The main risk factors associated with CHD in heterozygous FH are AH, age more than 40 y. o., complicated inheritance for cardiovascular diseases. The relation of LDL-C and IHD prevalence in FH patients is not linear. 

1. Hovingh G. K., Davidson M.H., Kastelein J.J.P., O’Connor A.M. Diagnosis and treatment of familial hypercholesterolaemia. European Heart Journal 2013; 34: 962–971.

2. Allard M.D., Saeedi R., Yousefi M., Frohlich J. Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort. Lipids in Health and Disease 2014, 13: 65 doi:10.1186/1476-511X-13-65.

3. Besseling J., Huijgen R., Martin S.S. et al. Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia. Atherosclerosis 2015; 246:1–6.

4. Besseling J., Kindt I., Hofc M. et al. Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: A study of a cohort of 14,000 mutation carriers Atherosclerosis 2014; 233:219–223.

5. Huijgen R., Hutten B.A, Kindt I., Vissers M.N., Kastelein J.J. Discriminative ability of LDL-cholesterol to identify patients with familial hypercholesterolemia: a cross-sectional study in 26,406 individuals tested for genetic FH. Circ Cardiovasc Genet 2012;5(3):354–9.

6. O'Brien E.C., Roe M.T., Fraulo E.S. et al. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry. Am Heart J. 2014; 167(3): 342–349.

7. Korneva V.A., Kuznetsova T.Yu., Bogoslovskaya T.Yu. et al. Modern diagnostics abilities of familial hypercholesterolemia before clinical features of atherosclerosis appearance. Atherosclerosis and dyslipidemias 2016;1(22):22–32.(Корнева В.А., Кузнецова Т.Ю., Богословская Т.Ю. и др. Современные возможности диагностики семейной гиперхолестеринемии до появления клинических проявлений атеросклероза. Атеросклероз и дислипидемии.2016;1(22): 22–32).

8. Di Angelantonio E, Gao P, Pennells L, et al. Lipid-related markers and cardiovascular disease prediction. JAMA 2012; 307: 2499–506

9. Ference B.A., Yoo W., Alesh I., et al. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomizationе analysis. J Am Coll Cardiol 2012; 60: 2631–76.

10. Meshkov A.N, Malyshev P.P., Kukharchuk V.V. Familial hypercholesterolemia in Russia: genetic and phenotypic characteristics. Ter Arkh. 2009; 81(9):23–8. Russian (Мешков А.Н., Малышев П.П., Кухарчук В.В. Семейная гиперхолестеринемия в России: генетическая и фенотипическая характеристика. Терапевтический архив. 2009; 81(9):23–8).

11. Miname M.H., Ribeiro M.S., Parga Filho J. et al. Evaluation of subclinical atherosclerosis by computed tomography coronary angiography and its association with risk factors in familial hypercholesterolemia. Atherosclerosis 2010; 213(2):486–91.

12. Jansen H., Samani N., Schunkert H. Mendelian randomization studies in coronary artery disease. European Heart Journal 2014; 35, 1917–1924.

13. Nordestgaard B.G., Chapman M.J., Humphries S.E. et al. European Atherosclerosis Society Consensus Panel Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013; 34(45):3478–90a.

14. Iperen Е., Sivapalaratnam S.,. Boekholdt S., Hovingh K. et al. Common genetic variants do not associate with CAD in familial hypercholesterolemia. European Journal of Human Genetics 2014; 22: 809–813.

15. Versmissen J., Oosterveer D.M., Yazdanpanah M. et al. Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach. Eur. J. Hum. Genet. 2015; 23: 381–387.